Randomized, Multicentre Study of the Efficacy and Tolerance of Azithromycin versus Clarithromycin in the Treatment of Adults with Mild to Moderate Community-Acquired Pneumonia

Abstract

 Adults with mild to moderate community-acquired pneumonia were treated with azithromycin (500 mg once daily for 3 days) or clarithromycin (250 mg twice daily for 10 days) and clinically assessed between days 3 and 7 and days 12 and 16. Patients classified as improved at the day 12–16 visit were also evaluated between days 19 and 23. Two hundred three… (More)
DOI: 10.1007/s100960050201

3 Figures and Tables

Topics

  • Presentations referencing similar topics